Taiwan medicine data and pricing are the newest addition to the Pharma14 platform

The Taiwan Ministry of Health reported that Taiwan’s population will increase till 2021, along with an increase in the population of seniors. As a result, national health expenditure will continue to increase. In 2017 , Taiwan’s national health expenditure amounted to US $37.5 billion, which is 6.4% of gross domestic product (GDP), which represents an increase of 3.7% over the previous year. About 60.8% of Taiwan’s healthcare expenditures are funded by the public sector, with the remaining 39.6% covered by the private sector. 

Pharma14 covers over 40,000 registered medicines in Taiwan including ex-factory tender pricing information.

Sample Taiwan data: Trastuzumab. Ex-factory tender pricing.

Taiwan Medicine Prices



Passeig del Ferrocarril 337, 4ª

Castelldefels 08860

Barcelona, Spain




Drug Price